Charles Bonnet syndrome improves when treatment is effective in age-related macular degeneration.
Singh
A
A
Sørensen
T L
TL
D000368:Aged; D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D005260:Female; D006212:Hallucinations / Q000188:drug therapy* / Q000523:psychology; D006801:Humans; D008268:Macular Degeneration / Q000188:drug therapy* / Q000523:psychology; D008297:Male; D008875:Middle Aged; D000069579:Ranibizumab; D012189:Retrospective Studies; D018709:Statistics, Nonparametric; D013577:Syndrome; D014786:Vision Disorders / Q000188:drug therapy* / Q000523:psychology; D014792:Visual Acuity / Q000187:drug effects
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069579:Ranibizumab